MedPath

广东恒瑞医药有限公司

Ownership
-
Established
2019-04-19
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Recaticimab for Injection

Product Name
艾心安
Approval Number
国药准字S20250002
Approval Date
Jan 8, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.